Robert L. Rosiello - 14 Apr 2023 Form 4 Insider Report for Evelo Biosciences, Inc.

Role
Director
Signature
/s/ Marella Thorell, Attorney-in-Fact for Robert L. Rosiello
Issuer symbol
EVLO on OTC
Transactions as of
14 Apr 2023
Net transactions value
$0
Form type
4
Filing time
18 Apr 2023, 17:12:44 UTC
Previous filing
18 Nov 2022
Next filing
12 Jun 2023
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction EVLO Stock Option (Right to Buy) Award $0 +40,000 $0.000000 40,000 14 Apr 2023 Common Stock 40,000 $0.1700 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option vests in 36 substantially equal monthly installments following the grant date and has a term of 10 years.